Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease.
AUTOR(ES)
Kovalchin, J P
RESUMO
The use of inhaled nitric oxide as a selective pulmonary vasodilator has expanded to include patients with congenital heart disease and pulmonary hypertension. The therapeutic and diagnostic roles of inhaled nitric oxide offer additional alternatives and benefits to these patients with pulmonary hypertension, particularly in the postoperative setting. This article reviews the background, mechanism of action, toxicities, and current clinical applications of inhaled nitric oxide in the child with congenital heart disease and pulmonary hypertension.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=325473Documentos Relacionados
- Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease.
- Nitric oxide treatment for fulminant pulmonary hypertension.
- Inhaled nitric oxide for the treatment of persistent pulmonary hypertension.
- PULMONARY HYPERTENSION IN CONGENITAL HEART DISEASE
- Radio-iodine in treatment of congenital heart disease with severe pulmonary hypertension.